Analyst Reco. Exelon Corporation

Equities

EXC

US30161N1019

Real-time Estimate Cboe BZX Other stock markets 14:38:35 2024-05-01 EDT			5-day change	1st Jan Change
37.97 ^USD	+1.04%		+0.24%	+5.46%

04-30	Exelon Keeps Quarterly Dividend at $0.38 a Share, Payable June 14 to Shareholders of Record May 13	MT
04-30	Exelon Corporation Declares Regular Quarterly Dividend, Payable on June 14, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating	04-23	MT
Scotiabank Adjusts Exelon's Price Target to $37 From $39	04-22	MT
BMO Capital Adjusts Exelon Price Target to $40 From $39	04-22	MT
Barclays Adjusts Price Target on Exelon to $39 From $36, Maintains Overweight Rating	03-14	MT
Wells Fargo Cuts Price Target on Exelon to $39 From $41, Maintains Equalweight Rating	02-22	MT
Exelon beats Q4 profit estimates on higher electricity rates	02-21	RE
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up	02-21	MT
Barclays Cuts Price Target on Exelon to $36 From $38, Maintains Overweight Rating	01-22	MT
BofA Adjusts Price Target on Exelon to $36 From $38, Keeps Neutral Rating	01-19	MT
In wait-and-see mode	01-10
Mizuho Securities Upgrades Exelon to Buy From Neutral, Raises Price Target to $39 From $36	01-10	MT
ANALYST RECOMMENDATIONS : Apple, Block, Palo Alto, Wise, Workday...	01-10
Seaport Downgrades Exelon to Neutral From Buy	01-08	MT
UBS Downgrades Exelon to Neutral From Buy, Adjusts Price Target to $37 From $47	01-02	MT
RBC Cuts Price Target on Exelon to $38 From $45 Amid Illinois Grid Plan Rejection, Keeps Sector Perform Rating	12-19	MT
Exelon 2025 EPS Forecast Lowered by Morgan Stanley Following Illinois Regulator's Rate Case Decision	12-18	MT
Mizuho Adjusts Exelon's Price Target to $36 From $40, Keeps Neutral Rating	12-18	MT
JPMorgan Downgrades Exelon to Neutral From Overweight, Cuts Price Target to $41 From $46	12-18	MT
Morgan Stanley Downgrades Exelon to Equalweight From Overweight, Cuts Price Target to $38 From $45 Amid 'Unfavorable' Illinois Rate Case Decision	12-18	MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce...	12-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Exelon Corporation

Equities

EXC

US30161N1019

Analyst Reco.

Filters